- Trials with a EudraCT protocol (1,128)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (47)
1,128 result(s) found for: Ventilation.
Displaying page 1 of 57.
EudraCT Number: 2007-006742-18 | Sponsor Protocol Number: P070106 | Start Date*: 2010-08-25 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Evaluation de l'intérêt de la loxapine dans le contrôle de l'agitation au cours du sevrage de la ventilation mécanique. Etude randomisée, contrôlée. | |||||||||||||
Medical condition: Agitation au cours du sevrage de la ventilation mécanique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001109-15 | Sponsor Protocol Number: BIOTOB | Start Date*: 2015-12-15 | |||||||||||
Sponsor Name:INSTITUTO DE INVESTIGACION SANITARIA LA FE | |||||||||||||
Full Title: A Phase III clinical trial randomized and blinded on the use of inhaled tobramycin compared with placebo in patients undergoing mechanical ventilation and colonized by Gram negative bacteria for ef... | |||||||||||||
Medical condition: critically ill patients undergoing mechanical ventilation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022679-71 | Sponsor Protocol Number: Xenon-MTH-Studie | Start Date*: 2011-01-07 | |||||||||||
Sponsor Name:Clinical Trials Center Aachen, University of Aachen | |||||||||||||
Full Title: Xenon and Therapeutical Hypothermia After Successful Cardiopulmonary Resuscitation | |||||||||||||
Medical condition: In this clinical trial will be checked, whether 2 hours ventilation with xenon has neuroprotetctive effect on the patients, which had out of hospital cardiac arrest and successful cardiopulmonary r... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002201-66 | Sponsor Protocol Number: CBYM338X2207 | Start Date*: 2013-11-01 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: An exploratory, randomized, double-blind, placebo-controlled study to investigate the effect of BYM338 on muscle in patients requiring prolonged mechanical ventilation | |||||||||||||
Medical condition: Group III failure to wean patients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003457-24 | Sponsor Protocol Number: P051018 | Start Date*: 2007-02-07 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Sevrage de la ventilation mécanique guidé par le peptide natriurétique de type B. | |||||||||||||
Medical condition: Patients sous ventilation mécanique. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003312-30 | Sponsor Protocol Number: 2012-24 | Start Date*: 2012-12-12 |
Sponsor Name:ASSISTANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: Interest of preemptive treatment with ganciclovir or acyclovir in patients requiring prolonged mechanical ventilation and have either a cytomegalovirus replication in blood or an herpes simplex vir... | ||
Medical condition: mechanically ventilated patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005849-16 | Sponsor Protocol Number: KIN001-203 | Start Date*: 2021-03-09 | |||||||||||
Sponsor Name:Kinarus AG | |||||||||||||
Full Title: An 8-week double-blind, randomized, placebo-controlled, phase II study evaluating the effects of oral pamapimod 150 mg with pioglitazone 10 mg daily on COVID-19 development in hospitalized patient... | |||||||||||||
Medical condition: COVID-19 development in hospitalized patients infected with SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003168-37 | Sponsor Protocol Number: Thllo | Start Date*: 2019-05-13 |
Sponsor Name:University Tuebingen | ||
Full Title: Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study | ||
Medical condition: Acute respiratory distress syndrome requiring mechanical ventilation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-005863-29 | Sponsor Protocol Number: HelmetHeparin | Start Date*: 2021-07-15 | |||||||||||||||||||||
Sponsor Name:ASST FATEBENEFRATELLI SACCO | |||||||||||||||||||||||
Full Title: Nebulised heparin in COVID-19-related ARDS patients undergoing non-invasive ventilation with helmet cPAP: a prospective, randomised, double blind, placebo-controlled, multicentre study | |||||||||||||||||||||||
Medical condition: COVID-19-related Acute Respiratory Distress Syndrome (ARDS) patients undergoing non-invasive ventilation with helmet continuous positive airway pressure (cPAP) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001236-10 | Sponsor Protocol Number: COVID-19 | Start Date*: 2020-03-31 |
Sponsor Name:Amsterdam UMC | ||
Full Title: COUNTER-COVID - Oral imatinib to prevent pulmonary vascular leak in Covid19 – a randomized, double --blind, placebo controlled, clinical trial in patients with severe Covid19 disease’ | ||
Medical condition: Covid19 is characterized by hypoxemic respiratory failure, caused by extensive vascular leak and pulmonary edema early in the course of disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001492-33 | Sponsor Protocol Number: CGE_2020_9 | Start Date*: 2020-04-10 |
Sponsor Name:Hôpital Fondation Adolphe de Rothschild | ||
Full Title: Interest in the administration of Dornase alpha aerosol in ARDS secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19 | ||
Medical condition: Patients on mechanical ventilation, inpatient resuscitation for ARDS, secondary to COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002411-26 | Sponsor Protocol Number: GO-SLEEP | Start Date*: 2019-10-09 | |||||||||||
Sponsor Name:CHU de Poitiers | |||||||||||||
Full Title: Impact of Gamma-OH on sleep in ICU patients difficult to wean from mechanical ventilation | |||||||||||||
Medical condition: Patients difficult to wean from mechanical ventilation in the ICU | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002509-22 | Sponsor Protocol Number: ID2687 | Start Date*: 2019-11-21 | |||||||||||
Sponsor Name:FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE | |||||||||||||
Full Title: Impact of totally transdermal sedation in the weaning from remifentanil infusion among critically ill patients undergoing mechanical ventilation: a pilot randomized-controlled Study | |||||||||||||
Medical condition: Invasive mechanical ventilation is a lifesaving intervention among critically ill patients. However, prolonged ventilation is associated with increased morbidity and mortality. Optimal processes fo... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001972-13 | Sponsor Protocol Number: COVID-19HD | Start Date*: 2020-05-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA | |||||||||||||
Full Title: Randomised controlled trial comparing efficacy and safety of high versus low low-molecular weight heparin dosages in hospitalised patients with severe COVID-19 pneumonia and coagulopathy not requir... | |||||||||||||
Medical condition: Hospitalized patients with severe COViD-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010366-28 | Sponsor Protocol Number: 69/09 | Start Date*: 2009-06-13 | |||||||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||||||||||||
Full Title: Effects of different doses of remifentanil in patients ventilated in Pressure Support Ventilation (PSV) vs Neurally Adjusted Ventilatory Assist (NAVA) | |||||||||||||||||||||||
Medical condition: Acute Respiratory Failure (ARF) or with a difficult weaning in patients ventilated | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001777-71 | Sponsor Protocol Number: RAVEN | Start Date*: 2020-05-06 | ||||||||||||||||
Sponsor Name:Guy’s and St Thomas' NHS Foundation Trust | ||||||||||||||||||
Full Title: Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patiENts - RAVEN | ||||||||||||||||||
Medical condition: Severe COVID-19 infection with risk of need for mechanical ventilation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-010555-28 | Sponsor Protocol Number: P071219 | Start Date*: 2009-06-22 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: NICOREA : Evaluation multicentrique d'une stratégie de substitution nicotinique par timbre transdermique lors du sevrage de la ventilation mécanique de patients fumeurs hospitalisés en réanimation | |||||||||||||
Medical condition: Les patients fumeurs sous ventilation mécanique . | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000748-24 | Sponsor Protocol Number: -- | Start Date*: 2018-08-09 |
Sponsor Name:VUmc | ||
Full Title: Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients. A randomized controlled pilot study. | ||
Medical condition: Some patients develop high respiratory drive during partially supported mechanical ventilation which is associated with lung and diaphragm injury and worse clinical outcome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000248-15 | Sponsor Protocol Number: Dartagnan3 | Start Date*: 2008-08-01 | |||||||||||
Sponsor Name:Association pour la promotion de la réanimation médicale à Tours | |||||||||||||
Full Title: Amikacine nébulisée à forte dose. Pharmacocinétique dans la pneumonie associée à la ventilation mécanique D’ARTAGNAN 3 | |||||||||||||
Medical condition: Ventilator associated pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000166-21 | Sponsor Protocol Number: 1 | Start Date*: 2007-06-22 | |||||||||||
Sponsor Name:Whipps Cross University Hospital | |||||||||||||
Full Title: A comparison of the efficacy of 10% lidocaine solution and EMLA cream as local anaesthetic for the insertion of tympanic membrane ventilation tubes. | |||||||||||||
Medical condition: Grommet/ventilation tube insertion in adults with otitis media with effusion (glue ear). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
